Bruton Tyrosine Kinase Inhibitor–Associated Pericardial Events by Agent and Generation - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Pericardial Complications Linked to Bruton Tyrosine Kinase Inhibitors: Comparisons by Agent and Generation

  • By

  • Vinicius De Sousa Barzon Serra

  • Ramzi Ibrahim

  • Julia Zanco

  • Amjed Al Abdel

  • Amal Youssef

  • Dina Hauptschein

  • Karam Albdour

  • Luke Dreher

  • Hema Narayanasamy

  • Kwan Lee

  • Balaji Tamarappoo

  • J. Christopher Ray

  • Talal Hilal

  • Luis R. Scott

  • Joerg Herrmann

  • Chadi Ayoub

  • Reza Arsanjani

  • November 9, 2026

Share

Original Source(s)

Bruton Tyrosine Kinase Inhibitor–Associated Pericardial Events by Agent and Generation

  • by Vinicius De Sousa Barzon Serra, Ramzi Ibrahim, Julia Zanco, Amjed Al Abdel, Amal Youssef, Dina Hauptschein, Karam Albdour, Luke Dreher, Hema Narayanasamy, Kwan Lee, Balaji Tamarappoo, J. Christopher Ray, Talal Hilal, Luis R. Scott, Joerg Herrmann, Chadi Ayoub, Reza Arsanjani

  • November 9, 2026

Related Content

Author Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

Organ Preservation in Rectal Adenocarcinoma—A Growing Practice With Promise and Pitfalls

Risk-Based Lung Cancer Screening for People Who Never Smoked